Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BPTH Bio-Path Holdings, Inc.

盘前交易 12-23 09:05:04 EST

1.26

-0.23

-15.44%

盘前1.24

-0.02-1.59%

09:01 EST

最高1.45	最低1.16	成交量379.28万
今开1.39	昨收1.49	日振幅19.46%
总市值542.67万	流通市值542.46万	总股本430.69万
成交额486.75万	换手率88.10%	流通股本430.52万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BPTH","market":"US","secType":"STK","nameCN":"Bio-Path Holdings, Inc.","latestPrice":1.26,"timestamp":1734728400000,"preClose":1.49,"halted":0,"volume":3792750,"hourTrading":{"tag":"盘前","latestPrice":1.24,"preClose":1.26,"latestTime":"09:01 EST","volume":81388,"amount":95649.65993400001,"timestamp":1734962513675},"delay":0,"floatShares":4305200,"shares":4306892,"eps":-13.740521,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.23,"latestTime":"12-23 09:05:04 EST","open":1.39,"high":1.45,"low":1.16,"amount":4867530.3924,"amplitude":0.194631,"askPrice":1.37,"askSize":100,"bidPrice":1.24,"bidSize":35,"shortable":0,"etf":0,"ttmEps":-13.740521,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"adjPreClose":1.26,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.24,"preClose":1.26,"latestTime":"09:01 EST","volume":81388,"amount":95649.65993400001,"timestamp":1734962513675},"postHourTrading":{"tag":"盘后","latestPrice":1.18,"preClose":1.26,"latestTime":"19:59 EST","volume":93070,"amount":115615.702,"timestamp":1734742772659},"volumeRatio":0.16644131171979137,"impliedVol":6.8861,"impliedVolPercentile":1},"requestUrl":"/m/hq/s/BPTH/tweets","defaultTab":"tweets","newsList":[{"id":"2492442600","title":"Bio-Path Holdings, Inc.盘中异动 早盘急速下跌7.45%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492442600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492442600?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:30","pubTimestamp":1734705023,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时30分，Bio-Path Holdings, Inc.股票出现异动，股价急速下挫7.45%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Humacyte, Inc.、Psyence Biomedical Ltd.、Aptose Biosciences, Inc.涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为1707.42%、76.55%、53.88%，振幅较大的相关个股有Polyrizon Ltd.、Aptose Biosciences, Inc.、冠科美博，振幅分别为6.21%、5.88%、5.34%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223023984cfbe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223023984cfbe1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":1},{"id":"1114601214","title":"暴涨406%并熔断！这一医药公司火了","url":"https://stock-news.laohu8.com/highlight/detail?id=1114601214","media":"Wind万得","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114601214?lang=zh_cn&edition=full","pubTime":"2024-12-20 11:07","pubTimestamp":1734664035,"startTime":"0","endTime":"0","summary":"香港万得通讯社报道，美东时间12月19日， Bio-Path Holdings股价盘中暴涨超406%，报3.39美元，并触发熔断机制。美股历史上，个股单日盘中暴涨400%以上的情况也非常少见。公司在完成临床前研究后，已开始动物实验以进一步确认BP1001-A的疗效，并计划于2025年开始早期人体试验。世界卫生组织数据显示，2022年全球有1.59亿儿童和青少年以及8.79亿成年人患有肥胖症。","market":"hk","thumbnail":"https://static.tigerbbs.com/8593d7bafc6da002b2ab4975d4711a90","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8593d7bafc6da002b2ab4975d4711a90"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c7d5dc247e4842683e20d8820e16915e","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"暴涨406%并熔断！这一医药公司火了","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPTH"],"gpt_icon":0},{"id":"2492170160","title":"BUZZ--美国股票走势-Paychex、RTX、波音公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492170160","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492170160?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:50","pubTimestamp":1734623434,"startTime":"0","endTime":"0","summary":".N美东时间10:30，道琼斯工业平均指数.DJI上涨0.33%，报42465.99点。标普500指数.SPX上涨0.34%，报5892.37点；纳斯达克综合指数.IXIC上涨0.30%，报19451.09点。nL4N3NK10M  ** CarMax KMX.N：BUZZ--该公司公布两年多来首次季度销售额增长后上涨。nL4N3NK141  ** Conagra Brands CAG.N:BUZZ - 在下调年度利润预期后下跌 nL4N3NK0ZT  ** Zoom Communications ZM.O:BUZZ - 因杰富瑞看好人工智能货币化计划而上涨 nL6N3NK0H3  ** Marker Therapeutics MRKR.O:BUZZ - 1600万美元私募后下滑 nL4N3NK15T  ** C3.ai AI.N:BUZZ - 因KeyBanc将其评级下调至 \"减持 \"而下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4T3NK1F5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAG","MU","BK4130","KBR","IE00B19Z3B42.SGD","SHCO","MRKR","LU0950375773.USD","ALT","KMX","IE00BFTCPJ56.SGD","TPR","ACN","BK4528","EPAM","BK4141","CTAS","BPTH","ZM","RTX","LU2360106780.USD","WGO","BA","TPET","OKTA","PTON","PAYX","APCX","IE00B3S45H60.SGD","BK4560","LU0823417737.USD","LU1228905540.USD","LW","VRTX","LU0661504455.SGD","SOC","PRFX","DRI","LU1571399168.USD","USB"],"gpt_icon":1},{"id":"1170079573","title":"Bio-Path开盘暴涨触发熔断，肥胖症实验性疗法取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1170079573","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170079573?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:42","pubTimestamp":1734619328,"startTime":"0","endTime":"0","summary":"计划于2025年开始早期人体试验。","market":"us","thumbnail":"https://static.tigerbbs.com/6ce1e2c9b06bd8104cffbddf43442c15","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ce1e2c9b06bd8104cffbddf43442c15"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c7d5dc247e4842683e20d8820e16915e","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Bio-Path Holdings周四暴涨，肥胖症实验性疗法取得积极结果","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPTH"],"gpt_icon":0},{"id":"2492312206","title":"BUZZ-Bio-Path 因肥胖症治疗临床前数据良好而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2492312206","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492312206?lang=zh_cn&edition=full","pubTime":"2024-12-19 20:55","pubTimestamp":1734612934,"startTime":"0","endTime":"0","summary":"    12月19日 - ** 药物开发商Bio-Path Holdings   的股价盘前翻了一番多，达到1.51美元 ** 该公司报告了一项临床前研究的积极结果，该研究测试其实验性疗法BP1001-A，以治疗2型糖尿病患者的肥胖症和相关代谢疾病。** 公司正在测试 BP1001-A，以一种名为 Grb2 的蛋白质为靶点，提高患者的胰岛素敏感性，降低血糖水平。** 公司称试验证实了 BP1001-A 在影响胰岛素信号传导方面的有效性** 公司称已开始动物实验，以确认 BP1001-A 的疗效，并计划于 2025 年开始早期人体试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c7d5dc247e4842683e20d8820e16915e","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2492718206","title":"Bio-Path Holdings, Inc.盘中异动 快速下跌5.23%报0.658美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492718206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492718206?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:14","pubTimestamp":1734534841,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日23时14分，Bio-Path Holdings, Inc.股票出现波动，股价大幅下挫5.23%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为2075.30%、422.93%、281.63%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为227.62%、96.72%、66.83%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218231402984cb379&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218231402984cb379&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2491669733","title":"Bio-Path Holdings, Inc.盘中异动 早盘急速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491669733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491669733?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:45","pubTimestamp":1734360342,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时45分，Bio-Path Holdings, Inc.股票出现波动，股价急速上涨5.14%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tonix Pharmaceuticals Holding Corp.、Viridian Therapeutics, Inc.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为40.05%、32.73%、30.31%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tonix Pharmaceuticals Holding Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为38.10%、19.33%、19.23%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121622454295ea1398&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121622454295ea1398&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2491396013","title":"Bio-Path Holdings, Inc.盘中异动 临近午盘大幅跳水6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491396013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491396013?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:50","pubTimestamp":1734022201,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日00时50分，Bio-Path Holdings, Inc.股票出现异动，股价急速下挫6.15%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Palisade Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3549.60%、908.16%、81.20%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为129.16%、86.92%、80.04%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213005001a1e99033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213005001a1e99033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2490065010","title":"Bio-Path Holdings, Inc.盘中异动 股价大涨5.42%报0.675美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490065010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490065010?lang=zh_cn&edition=full","pubTime":"2024-12-11 00:02","pubTimestamp":1733846574,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日00时02分，Bio-Path Holdings, Inc.股票出现波动，股价急速拉升5.42%。截至发稿，该股报0.675美元/股，成交量1.6926万股，换手率0.39%，振幅7.44%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211000254984b10ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211000254984b10ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2489112539","title":"Bio-Path Holdings, Inc.盘中异动 股价大跌5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489112539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489112539?lang=zh_cn&edition=full","pubTime":"2024-12-05 01:13","pubTimestamp":1733332411,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日01时13分，Bio-Path Holdings, Inc.股票出现波动，股价快速下跌5.62%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Exicure, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为3358.15%、264.96%、132.21%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、Eterna Therapeutics Inc.，振幅分别为237.89%、61.31%、55.22%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120501133198e56411&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120501133198e56411&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2488208539","title":"Bio-Path Holdings, Inc.盘中异动 下午盘股价大跌5.22%报0.704美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488208539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488208539?lang=zh_cn&edition=full","pubTime":"2024-12-04 03:06","pubTimestamp":1733252786,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日03时06分，Bio-Path Holdings, Inc.股票出现波动，股价快速下跌5.22%。截至发稿，该股报0.704美元/股，成交量3.2776万股，换手率0.76%，振幅5.79%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204030626a26a0dae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204030626a26a0dae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2486030879","title":"Bio-Path Holdings, Inc.盘中异动 大幅跳水5.41%报0.761美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486030879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486030879?lang=zh_cn&edition=full","pubTime":"2024-11-28 00:05","pubTimestamp":1732723533,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日00时05分，Bio-Path Holdings, Inc.股票出现波动，股价大幅下挫5.41%。截至发稿，该股报0.761美元/股，成交量7458股，换手率0.17%，振幅4.85%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112800053398e44f90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112800053398e44f90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2486201009","title":"Bio-Path Holdings, Inc.盘中异动 早盘快速跳水5.54%报0.760美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486201009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486201009?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:32","pubTimestamp":1732631574,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时32分，Bio-Path Holdings, Inc.股票出现异动，股价快速跳水5.54%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Poseida Therapeutics, Inc.、Arrowhead Pharmaceuticals, Inc.、Fate Therapeutics, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、Cognition Therapeutics, Inc.较为活跃，换手率分别为13.41%、10.06%、8.43%，振幅较大的相关个股有Caribou Biosciences, Inc.、Cabaletta Bio, Inc.、Fate Therapeutics, Inc.，振幅分别为13.61%、13.54%、11.78%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223254a25745e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223254a25745e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2486303210","title":"Bio-Path Holdings, Inc.盘中异动 临近午盘急速跳水6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486303210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486303210?lang=zh_cn&edition=full","pubTime":"2024-11-26 00:30","pubTimestamp":1732552257,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日00时30分，Bio-Path Holdings, Inc.股票出现异动，股价快速下跌6.46%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Exicure, Inc.涨幅较大，木薯科学、Cognition Therapeutics, Inc.、Exicure, Inc.较为活跃，换手率分别为121.84%、103.03%、78.40%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Exicure, Inc.，振幅分别为94.06%、78.65%、75.84%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126003057abde3276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126003057abde3276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2485200478","title":"Bio-Path Holdings, Inc.2024财年第三财季实现净利润-2.12百万美元，同比增加33.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485200478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485200478?lang=zh_cn&edition=full","pubTime":"2024-11-24 00:00","pubTimestamp":1732377622,"startTime":"0","endTime":"0","summary":"11月24日，Bio-Path Holdings, Inc.公布财报，公告显示公司2024财年第三财季净利润为-2.12百万美元，同比增加33.75%；其中营业收入为0.00美元，每股基本收益为-0.70美元。机构评级：截至2024年11月24日，当前有1家机构对Bio-Path Holdings, Inc.目标价做出预测，其中目标均价为12.00美元，其中最低目标价为12.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000042a2504563&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000042a2504563&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH"],"gpt_icon":0},{"id":"2485269718","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485269718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485269718?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:31","pubTimestamp":1732285915,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时31分，Bio-Path Holdings, Inc.股票出现波动，股价大幅跳水6.01%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Molecular Templates, Inc.、Exicure, Inc.较为活跃，换手率分别为516.45%、62.47%、36.75%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cyclerion Therapeutics, Inc.、Exicure, Inc.，振幅分别为19.38%、14.78%、10.96%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223155a24e2071&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223155a24e2071&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2485125414","title":"Bio-Path Holdings, Inc.盘中异动 大幅拉升7.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485125414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485125414?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:23","pubTimestamp":1732206220,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时23分，Bio-Path Holdings, Inc.股票出现波动，股价大幅拉升7.26%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为769.91%、483.54%、118.09%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122002340a24ba772&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122002340a24ba772&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2484692350","title":"Bio-Path Holdings, Inc.盘中异动 早盘急速拉升6.65%报0.800美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484692350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484692350?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:38","pubTimestamp":1732027098,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时38分，Bio-Path Holdings, Inc.股票出现异动，股价快速上涨6.65%。截至发稿，该股报0.800美元/股，成交量1899股，换手率0.04%，振幅4.20%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922381898e4381c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922381898e4381c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2484561679","title":"Bio-Path Holdings, Inc.盘中异动 早盘快速下挫5.85%报0.765美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484561679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484561679?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:39","pubTimestamp":1731940746,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时39分，Bio-Path Holdings, Inc.股票出现波动，股价快速下挫5.85%。截至发稿，该股报0.765美元/股，成交量2.1121万股，换手率0.57%，振幅6.15%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822390698e4340f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822390698e4340f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2483374757","title":"Bio Path 控股公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483374757","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483374757?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:31","pubTimestamp":1731681097,"startTime":"0","endTime":"0","summary":"Bio Path 控股公司公布截至 9 月 30 日的季度业绩 - 收益摘要Bio Path Holdings Inc BPTH.OQ报告，截至9月30日的季度调整后每股亏损70美分，高于去年同期的每股收益6.40美元。Bio Path 控股公司本季度每股收益为亏损 70 美分。该公司当季亏损 212 万美元。Bio Path Holdings Inc 本季度股价下跌了 1.1%，今年迄今为止下跌了 90.3%。华尔街对 Bio Path Holdings Inc 的 12 个月目标价中位数为 20.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4T3MM15Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPTH","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biopathholdings.com","stockEarnings":[{"period":"1week","weight":0.9056},{"period":"1month","weight":0.5996},{"period":"3month","weight":0.4141},{"period":"6month","weight":-0.4028},{"period":"1year","weight":-0.8552},{"period":"ytd","weight":-0.8639}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-path Holdings, Inc.该公司成立于2007年5月10日。该公司是一家临床和临床前阶段专注于肿瘤学的RNAi纳米颗粒药物开发公司，利用一种新技术实现全身递送，用于对任何在疾病中过度表达的基因产物进行靶点特异性蛋白质抑制。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.055835},{"month":2,"riseRate":0.4,"avgChangeRate":0.01406},{"month":3,"riseRate":0.6,"avgChangeRate":0.683886},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.127567},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.053526},{"month":6,"riseRate":0.545455,"avgChangeRate":0.01417},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.105842},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.169267},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.091013},{"month":10,"riseRate":0.545455,"avgChangeRate":0.085712},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.115921},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.042405}],"exchange":"NASDAQ","name":"Bio-Path Holdings, Inc.","nameEN":"Bio-Path"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bio-Path Holdings, Inc.,BPTH,Bio-Path Holdings, Inc.股票,Bio-Path Holdings, Inc.股票老虎,Bio-Path Holdings, Inc.股票老虎国际,Bio-Path Holdings, Inc.行情,Bio-Path Holdings, Inc.股票行情,Bio-Path Holdings, Inc.股价,Bio-Path Holdings, Inc.股市,Bio-Path Holdings, Inc.股票价格,Bio-Path Holdings, Inc.股票交易,Bio-Path Holdings, Inc.股票购买,Bio-Path Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}